Aardvark Therapeutics, Inc. Common Stock (AARD) Research Hub

Aardvark Therapeutics, Inc. Common Stock (AARD) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 5.13 USD (+4.27%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.02, market cap 0.13B. This hub links to the full technical, earnings and options research available for AARD.

Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close5.13 USD (+4.27%)
52-week range3.65 USD – 8.12 USD
Trend regimeRange
14-day RSI23 (Oversold)
Trailing P/E-2.02
Market cap0.13B
Dividend yield0.00%
Next earnings2026-08-12

Available research for AARD

Earnings

AARD earnings: next report 2026-08-12, real EPS beat/miss history, analyst consensus Buy, P/E -2.02. Updated 2026-07-23.

Options: Covered Call

Covered Call on AARD: how it works, illustrative setup around the real 5.13 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on AARD: how it works, illustrative setup around the real 5.13 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on AARD: how it works, illustrative setup around the real 5.13 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

AARD technical analysis: range, last 5.13 USD, RSI 23, 52w range 3.65 USD–8.12 USD, real support/resistance. Updated 2026-09-11.

Frequently asked questions

What sector is AARD in?

Aardvark Therapeutics, Inc. Common Stock (AARD) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is AARD in an uptrend or downtrend?

As of 2026-09-11, AARD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is AARD's trailing P/E ratio?

AARD's trailing P/E is -2.02, with a market cap of 0.13B. See the earnings research page for full valuation detail.

When does AARD next report earnings?

AARD is next scheduled to report earnings on 2026-08-12, with a consensus EPS estimate of -0.87 USD.